Paul Saladino Human Evidence: Surveys, Trials Gap, and What Lennerz Actually Is

Reach is not a methods section. Before accepting species-optimal diet claims, ask what study design produced the number—and whether the sample already believed the brand.

This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.

What does Lennerz 2021 actually show?

Self-selected adults reporting carnivore adherence with high satisfaction and heterogeneous metabolic markers; LDL often high in lipid subsets.

Useful as descriptive epidemiology of a subculture—not as proof of cardiovascular protection.

Never launder survey design into “clinical trial” language in headlines.

What is missing relative to guideline patterns?

Hard-outcome RCTs comparable to PREDIMED-class Mediterranean evidence are absent for animal-based/carnivore protocols.

Adherence biomarkers, long follow-up, and representative sex/age sampling remain scarce.

Mainstream dietetics still frames pure carnivore as fad-class relative to pattern evidence.

How should editors hierarchy the claims?

A/B: UPF reduction, protein adequacy, some short-term weight/symptom changes in motivated people under monitoring.

C: structured elimination as time-limited experiment with labs.

D: universal optimality, plant-poison absolutism, disease-cure organ capsules, raw-milk safety marketing.

What reader checklist prevents overclaim?

Name design (survey vs RCT). Name endpoint (satisfaction vs MI). Name population (self-selected men ≠ pregnant women).

Demand ApoB context when LDL soars. Prefer dual sources over single influencer PDFs.

Update when true trials appear—do not freeze identity around 2021 survey memes.

Sources: Lennerz et al. 2021 carnivore survey; PREDIMED 2018; Today's Dietitian fad diets context.

Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.